None listed
Conditions
Brief summary
Supplemental oxygen therapy is a common therapeutic intervention for neonates as an integral part of respiratory support in the NICU. To our knowledge, there are no detailed public datasets with sufficiently high sampling rates describing the physiological responses of patients to adjustments in oxygen therapy. This study aims to collect data from infants who are prescribed oxygen therapy. The observation period will be up to 24 hours after enrolment. The use of real-world data will help inform the development of future respiratory support devices
Interventions
This observational study is to gather physiological information from infants who are prescribed oxygen therapy during non-invasive respiratory support. Participants will receive the standard care before, during, and after completion of this trial There is no direct patient's involvement. The data will be collected from the patients' observational chart, medical history, and Phillips IntelleVue monitoring system (that continuously tracks a patient’s vital signs and ventilator parameters). The following parameters will be recorded from the observational chart: vital signs, blood gases, ventilation modes and parameters, incubator parameters. The duration of the observation period - is up to 24 hours.
Sponsors
Eligibility
Inclusion criteria
1. Patients who require supplemental oxygen therapy 2. Provision of signed and dated informed consent from the parent/legal guardian 3. Availability for the duration of the study (up to 6 hours of oxygen therapy predicted within a 24-hour observation period)
Exclusion criteria
1. Patients who are intubated 2. Involvement in another investigational study at the same time that may affect the results of this study